Cancidas and disease progression Patient Reports February 10, 2012

Cancidas Side Effects Report #4898163-7
Cancidas side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Male patient, 32 years of age, was diagnosed with zygomycosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aplasia pure red cell, disease progression, endocarditis , septic embolus. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE, AMPHOTERICIN B, POSACONAZOLE. Patient died.

Cancidas Side Effects Report #5097758-8
Cancidas side effect was reported by a Consumer or non-health professional from FRANCE on Aug 18, 2006. Male patient, 67 years of age, was diagnosed with systemic candida and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aspergillosis, cellulitis , disease progression, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with AMIKACIN SULPHATE, AMOXICILLIN, AMPHOTERICIN B, ASPIRIN, BISOPROLOL FUMARATE, CASPOFUNGIN ACETATE, DIGOXIN. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #5108666-8
Cancidas side effect was reported by a Consumer or non-health professional from FRANCE on Aug 18, 2006. Male patient, 67 years of age, was diagnosed with systemic candida and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cellulitis , disease progression, sepsis , systemic candida. Cancidas dosage: unknown. During the same period patient was treated with AMIKACIN SULPHATE, AMOXICILLIN, AMPHOTERICIN B, ASPIRIN, BISOPROLOL FUMARATE, CASPOFUNGIN ACETATE, DIGOXIN. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #5739708-4
Cancidas side effect was reported by a Consumer or non-health professional from GERMANY on May 01, 2008. Male patient, 53 years of age, was diagnosed with systemic candida and was treated with Cancidas. After drug was administered, patient experienced the following side effects: circulatory collapse, disease progression, hepatitis toxic, hypotension, infection , pancreatic pseudocyst, septic shock. Cancidas dosage: 150 MG/DAILY IV. During the same period patient was treated with ALBUMIN, AMINO ACIDS, AMIODARONE, BISOPROLOL FUMARATE, BUTYLSCOPOLAMINE BROMIDE, CALCIUM, CHOLECALCIFEROL. Patient died.


Cancidas Side Effects Report #5226761-X
Cancidas side effect was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Jan 24, 2007. Female patient, 79 years of age, was diagnosed with candidiasis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, disease progression, enterococcal infection, hyperbilirubinaemia. Cancidas dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, AMLODIPINE BESYLATE, ANTIMICROBIAL, AZTREONAM, CEFTAZIDIME, CIPROFLOXACIN, FAMOTIDINE, FENTANYL CITRATE. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #5742509-4
Cancidas side effect was reported by a Physician from SPAIN on Apr 30, 2008. Female patient, 42 years of age, was diagnosed with aspergillosis, cytomegalovirus infection  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aspergillosis, condition aggravated, cytomegalovirus infection , disease progression, enterocolitis, escherichia infection, hepatotoxicity, nephropathy toxic, renal failure chronic. Cancidas dosage: unknown. During the same period patient was treated with DURAGESIC. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #5785334-0
Cancidas side effect was reported by a Physician from CZECH REPUBLIC on June 09, 2008. Male patient, 35 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: disease progression. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE. Patient died.

Cancidas Side Effects Report #5796716-5
Cancidas side effect was reported by a Physician from CZECH REPUBLIC on June 09, 2008. Male patient, 35 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: disease progression, treatment failure. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE. Patient died.

Cancidas Side Effects Report #4863091-X
Cancidas side effect was reported by a Physician from CANADA on Dec 08, 2005. Female patient, 49 years of age, was diagnosed with abdominal infection, candidiasis, gastric volvulus, gastric perforation and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral artery embolism, cerebral disorder, cryptogenic organizing pneumonia, disease progression, respiratory moniliasis, septic embolus, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with AMPICILLIN, CIPROFLOXACIN, METRONIDAZOLE. Patient was hospitalized. Patient died.


Cancidas Side Effects Report #5090887-4
Cancidas side effect was reported by a Consumer or non-health professional from GERMANY on Aug 04, 2006. Male patient, 76 years of age, was treated with Cancidas. After drug was administered, patient experienced the following side effects: disease progression. Cancidas dosage: 50 MG/DAILY IV. Patient died.

Cancidas Side Effects Report #4766141-4
Cancidas side effect was reported by a Consumer or non-health professional from BELGIUM on Aug 24, 2005. Male patient, 72 years of age, was treated with Cancidas. After drug was administered, patient experienced the following side effects: disease progression, lung infiltration, respiratory failure. Cancidas dosage: 50 MG/DAILY, IV. During the same period patient was treated with DUOVENT, MEROPENEM, VANCOMYCIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #4768246-0
Cancidas side effect was reported by a Consumer or non-health professional from BELGIUM on Sept 01, 2005. Male patient, 72 years of age, was treated with Cancidas. After drug was administered, patient experienced the following side effects: disease progression, lung infiltration, respiratory failure. Cancidas dosage: 50 MG/DAILY, IV. During the same period patient was treated with DUOVENT, MEROPENEM, VANCOMYCIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.